These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32432999)

  • 1. Kolliphor® HS 15-cyclodextrin Complex for the Delivery of Voriconazole: Preparation, Characterization, and Antifungal Activity.
    Li Y; Zhu C; Wu H; Pan H; Liu H
    Curr Drug Metab; 2020; 21(5):379-389. PubMed ID: 32432999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
    Tian B; Yan Q; Wang J; Ding C; Sai S
    Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
    [No Abstract]   [Full Text] [Related]  

  • 3. Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies.
    El-Emam GA; Girgis GNS; El-Sokkary MMA; El-Azeem Soliman OA; Abd El Gawad AEGH
    Int J Nanomedicine; 2020; 15():7825-7840. PubMed ID: 33116503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents.
    Ravichandran V; Kesavan V; Cojean S; Loiseau PM; Jayakrishnan A
    Curr Drug Deliv; 2018; 15(7):1028-1037. PubMed ID: 29732967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Different Approaches for Oral Administration of Voriconazole Loaded Formulations: Electrospun Fibers versus β-Cyclodextrin Complexes.
    Siafaka PI; Üstündağ Okur N; Mone M; Giannakopoulou S; Er S; Pavlidou E; Karavas E; Bikiaris DN
    Int J Mol Sci; 2016 Feb; 17(3):282. PubMed ID: 26927072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity.
    Veloso DFMC; Benedetti NIGM; Ávila RI; Bastos TSA; Silva TC; Silva MRR; Batista AC; Valadares MC; Lima EM
    Drug Deliv; 2018 Nov; 25(1):1585-1594. PubMed ID: 30044149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bigger Data Approach to Analysis of Essential Oils and Their Antifungal Activity against
    Powers CN; Satyal P; Mayo JA; McFeeters H; McFeeters RL
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
    Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
    Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.
    Hafner V; Czock D; Burhenne J; Riedel KD; Bommer J; Mikus G; Machleidt C; Weinreich T; Haefeli WE
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2596-602. PubMed ID: 20368400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
    Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
    Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
    Pawar P; Kashyap H; Malhotra S; Sindhu R
    Biomed Res Int; 2013; 2013():341218. PubMed ID: 23762839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: In vitro characterization and in vivo permeation.
    Zhou T; Zhu L; Xia H; He J; Liu S; He S; Wang L; Zhang J
    Eur J Pharm Sci; 2017 Nov; 109():288-296. PubMed ID: 28823856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
    Kim SH; Kwon JC; Park C; Han S; Yim DS; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Choi JH; Yoo JH; Lee DG; Lee JW
    Mycoses; 2016 Oct; 59(10):644-51. PubMed ID: 27324913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kolliphor® HS 15 Micelles for the Delivery of Coenzyme Q10: Preparation, Characterization, and Stability.
    Liu L; Mao K; Wang W; Pan H; Wang F; Yang M; Liu H
    AAPS PharmSciTech; 2016 Jun; 17(3):757-66. PubMed ID: 26340950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug.
    Sayed S; Elsayed I; Ismail MM
    Int J Pharm; 2018 Oct; 549(1-2):249-260. PubMed ID: 30077759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced skin deposition and delivery of voriconazole using ethosomal preparations.
    Faisal W; Soliman GM; Hamdan AM
    J Liposome Res; 2018 Mar; 28(1):14-21. PubMed ID: 27667097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA; Fu Y; Ibrahim AS; Mortara LA; Shafiq MC; Edwards JE; Criddle RS
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.